Skip to main content

Big Buys in Biotech

Every weekend, I dig into our insider activity tracker looking for the biggest conviction buys — and this week, we’ve got heavy hitters across capital markets, biotech, real estate, and software.

Here’s the most notable activity:

Let’s start with the standout: BGC Group $BGC. Cantor Fitzgerald dropped a staggering $82.6 million into shares. 

Few Form 4 filings this year have come close in terms of size.

Over in biotech, Zenas Biopharma $ZBIO broke to new highs after Fairmount Funds Management scooped up more than $6 million worth of stock. 

When a specialist fund makes a move like that, it usually means they see serious upside ahead.

Meanwhile, Twist Bioscience $TWST is seeing quiet but steady accumulation. 

Artisan Partners bumped their stake from 8.45% to 10.6%, showing continued confidence in the company’s long-term potential.

In software, Philotimo Fund made its presence felt with a new 7.60% position in eGain $EGAN. 

A fresh 13D filing like this often signals that an investor plans to get more involved.

On the real estate front, Agree Realty $ADC got insider support from director John Rakolta Jr., who picked up roughly $1.77 million in shares.

Even on the political side, money’s moving into stocks. 

Senator John Hickenlooper disclosed a purchase between $100K and $250K in Palo Alto Networks $PANW.

If you're not a member of Hot Corner Insider and want access to exclusive trade ideas, weekly conference calls, and deep dive reports, join us risk-free.

Happy Sunday.

Steve

 

 

Steve